Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  3, 958 - 965 (2002)
Published online: 23 September 2002; | doi:10.1038/ni842

BAFF-induced NEMO-independent processing of NF-kappaB2 in maturing B cells

Estefania Claudio, Keith Brown, Sun Park, Hongshan Wang & Ulrich Siebenlist

Laboratory of Immunoregulation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1876, USA.

Correspondence should be addressed to Ulrich Siebenlist us3n@nih.gov
NF-kappaB is usually activated by signal-induced, ubiquitin-mediated degradation of its inhibitor, IkappaB. This process is initiated by phosphorylation of IkappaB by the IkappaB kinase (IKK) complex, predominantly by the IKKbeta catalytic subunit, and requires the regulatory subunit IKKbold gamma (NEMO). Another activation pathway, with no known physiological inducers, involves ubiquitin-mediated processing of the NF-kappaB2 inhibitory protein p100 and is dependent on phosphorylation of p100 by IKKalpha. We show here that B cell−activating factor (BAFF) activates this second pathway and that this requires the BAFF receptor (BAFF-R), the NF-kappaB−inducing kinase (NIK) and protein synthesis, but not NEMO. This NEMO-independent cascade is physiologically relevant for the survival and, hence, progression of maturing splenic B cells.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
See also: News and Views by Sun & Kincade
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy